All In Biotech

Drug Trial Radar · NCT00386282

Acceptability and Feasibility of Medical Abortion Using Mifepristone and Buccal Misoprostol

Acceptability and Feasibility of Medical Abortion in Mexico, Puerto Rico, Armenia and Azerbaijan: A Study of Buccal Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days' Gestation

Last checked: Nov 20, 2026Latest source record: Jul 30, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

1,250

Actual

Start

Sep 2006

Primary completion

Mar 2011

Study completion Mar 2011

Sponsor

Lead sponsor
Gynuity Health ProjectsAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 11, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study examined the acceptability and feasibility of introducing a mifepristone-misoprostol regimen of medical abortion into abortion services in two private clinics in Puerto Rico; 2 clinics in Baku, Azerbaijan; 3 clinics in Yerevan, Armenia; and 4 clinics in Mexico City. It was hypothesized that the study regimen would be both acceptable and efficacious.

Conditions

  • Abortion, First Trimester

Interventions

  • mifepristone-misoprostol treatmentDrug

    200 mg mifepristone followed by 800 mcg buccal misoprostol 24-48 hours after the mifepristone.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. efficacyTime frame: 15 days

Locations

11 sites in 4 countries. Site status is shown where the registry gives one.

  • Center for Family Planning and Sexual Health

    Yerevan, Armenia

  • Institute of Perinatology, Obstetrics and Gynecology

    Yerevan, Armenia

  • State Medical University

    Yerevan, Armenia

  • Family Planning Center

    Baku, Azerbaijan

  • Scientific Research Institute of Obstetrics and Gynecology

    Baku, Azerbaijan

  • C.S. Beatriz Velasco Aleman

    Mexico City, Federal District, Mexico

  • C.S. Santa Catarina

    Mexico City, Federal District, Mexico

  • H.G. Enrique Cabrera

    Mexico City, Federal District, Mexico

  • H.M.I Inguaran

    Mexico City, Federal District, Mexico

  • Clinica de Planificacion Familiar

    Lomas Verdes, Bayamon, Puerto Rico

  • Woman's Metropolitan Center

    San Juan, Puerto Rico

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.